logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

£10,000 for best use of Pupil Premium

15 May 2012

Yesterday, Nick Clegg unveiled plans to introduce a £10,000 reward for the 50 schools that make the best use of the Pupil Premium and do the most to boost results of the poorest pupils.

Pupil Premium is an additional £600 funding per pupil eligible to receive free school meals, introduced with the intention of closing the gap between richer and poorer pupils. However, with funding cuts across the board, it may be difficult for schools to make the best use of these additional funds with some concerned that the extra money will simply plug funding gaps.

The government aims to encourage good practice in schools, although is introducing competition over funding the best way to achieve this? It is important all schools are fully and fairly resourced and that the most vulnerable children are provided for. The assessment process for the reward must take this into account as there is a risk that the most innovative school may not necessarily target the most vulnerable pupils.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up